Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
—
—
—
—
—
—
—
5 Years
Score—
Net Growth—
Net Trend—
Net Income Consistency—
Rev Growth—
Rev Trend—
Revenue Consistency—
Evaxion Biotech AS fundamental performance
Across Evaxion Biotech AS's full reported history, from 2021 to 2025, revenue grew from $ 0.00 to $ 7M and net income went from -$ 24M to -$ 7M. Revenue increased in 75% of the years measured; net income in 100%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 3.07 | — |
1 Year2025-08-12 | $ 2.85 | 7.72% |
5 Years2021-08-12 | $ 290.00 | -98.94% |
All Time2021-02-05 | $ 494.50 | -99.38% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-02-05 |
|---|---|---|---|---|
| Price | $ 3.07 | $ 2.85 | $ 290.00 | $ 494.50 |
| Return | — | 7.72% | -98.94% | -99.38% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 7M | -$ 7M | $ 23M |
| 2024 | $ 3M | -$ 10M | $ 5M |
| 2023 | $ 73K | -$ 22M | $ 5M |
| 2022 | $ 0.00 | -$ 23M | $ 13M |
| IPO2021 | $ 0.00 | -$ 24M | $ 32M |
Explore beyond EVAX
You're looking at Evaxion Biotech AS. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
